APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rituximab Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rituximab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174033160322 December 2025190 pages

Choose your research edition.

Industry ResearchRituximab Injection Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Rituximab Injection Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Rituximab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rituximab Injection Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Rituximab Injection Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Rituximab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Rituximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rituximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rituximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rituximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rituximab Injection include Innovent Biologics, Roche, Pfizer, Fosun-Pharmaceutical, Shanghai Henlius Biotech, Amgen, Zenotech Laboratories, TRPharma and Probiomed, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rituximab Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rituximab Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rituximab Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rituximab Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Rituximab Injection Segment by Company

Innovent Biologics

Roche

Pfizer

Fosun-Pharmaceutical

Shanghai Henlius Biotech

Amgen

Zenotech Laboratories

TRPharma

Probiomed

Lexicare Pharma

Kavya Pharma

Intas Pharmaceuticals

Hetero Group

Healthiza Lifescience

Dr Reddy’s Laboratories

Celltrion

Cadila Pharmaceuticals

Rituximab Injection Segment by Type

100 ml

500 ml

Rituximab Injection Segment by Application

Hospitals

Clinics

Others

Rituximab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rituximab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rituximab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rituximab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rituximab Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rituximab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rituximab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Rituximab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Rituximab Injection Industry Trends Table 2. Rituximab Injection Industry Drivers Table 3. Rituximab Injection Industry Opportunities and Challenges Table 4. Rituximab Injection Industry Restraints Table 5. Global Rituximab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Rituximab Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Rituximab Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Rituximab Injection Sales Market Share by Manufacturers Table 9. Global Rituximab Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Rituximab Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Rituximab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Rituximab Injection Manufacturers, Product Type & Application Table 13. Global Rituximab Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Rituximab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100 ml Table 17. Major Manufacturers of 500 ml Table 18. Global Rituximab Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Rituximab Injection Sales by Type (2021-2026) & (k units) Table 20. Global Rituximab Injection Sales by Type (2027-2032) & (k units) Table 21. Global Rituximab Injection Sales Market Share by Type (2021-2026) Table 22. Global Rituximab Injection Sales Market Share by Type (2027-2032) Table 23. Global Rituximab Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Rituximab Injection Revenue by Type (2021-2026) & (k units) Table 25. Global Rituximab Injection Revenue by Type (2027-2032) & (k units) Table 26. Global Rituximab Injection Revenue Market Share by Type (2021-2026) Table 27. Global Rituximab Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Others Table 31. Global Rituximab Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Rituximab Injection Sales by Application (2021-2026) & (k units) Table 33. Global Rituximab Injection Sales by Application (2027-2032) & (k units) Table 34. Global Rituximab Injection Sales Market Share by Application (2021-2026) Table 35. Global Rituximab Injection Sales Market Share by Application (2027-2032) Table 36. Global Rituximab Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Rituximab Injection Revenue by Application (2021-2026) & (k units) Table 38. Global Rituximab Injection Revenue by Application (2027-2032) & (k units) Table 39. Global Rituximab Injection Revenue Market Share by Application (2021-2026) Table 40. Global Rituximab Injection Revenue Market Share by Application (2027-2032) Table 41. Global Rituximab Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Rituximab Injection Sales by Region (2021-2026) & (k units) Table 43. Global Rituximab Injection Sales Market Share by Region (2021-2026) Table 44. Global Rituximab Injection Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Rituximab Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Rituximab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Rituximab Injection Sales by Country (2021-2026) & (k units) Table 48. North America Rituximab Injection Sales by Country (2027-2032) & (k units) Table 49. Europe Rituximab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Rituximab Injection Sales by Country (2021-2026) & (k units) Table 51. Europe Rituximab Injection Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Rituximab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Rituximab Injection Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Rituximab Injection Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Rituximab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Rituximab Injection Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Rituximab Injection Sales by Country (2027-2032) & (k units) Table 58. Global Rituximab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Rituximab Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Rituximab Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Rituximab Injection Revenue Market Share by Region (2021-2026) Table 62. Global Rituximab Injection Revenue Market Share by Region (2027-2032) Table 63. Innovent Biologics Company Information Table 64. Innovent Biologics Business Overview Table 65. Innovent Biologics Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Innovent Biologics Rituximab Injection Product Portfolio Table 67. Innovent Biologics Recent Development Table 68. Roche Company Information Table 69. Roche Business Overview Table 70. Roche Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Roche Rituximab Injection Product Portfolio Table 72. Roche Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pfizer Rituximab Injection Product Portfolio Table 77. Pfizer Recent Development Table 78. Fosun-Pharmaceutical Company Information Table 79. Fosun-Pharmaceutical Business Overview Table 80. Fosun-Pharmaceutical Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Fosun-Pharmaceutical Rituximab Injection Product Portfolio Table 82. Fosun-Pharmaceutical Recent Development Table 83. Shanghai Henlius Biotech Company Information Table 84. Shanghai Henlius Biotech Business Overview Table 85. Shanghai Henlius Biotech Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shanghai Henlius Biotech Rituximab Injection Product Portfolio Table 87. Shanghai Henlius Biotech Recent Development Table 88. Amgen Company Information Table 89. Amgen Business Overview Table 90. Amgen Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Amgen Rituximab Injection Product Portfolio Table 92. Amgen Recent Development Table 93. Zenotech Laboratories Company Information Table 94. Zenotech Laboratories Business Overview Table 95. Zenotech Laboratories Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Zenotech Laboratories Rituximab Injection Product Portfolio Table 97. Zenotech Laboratories Recent Development Table 98. TRPharma Company Information Table 99. TRPharma Business Overview Table 100. TRPharma Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. TRPharma Rituximab Injection Product Portfolio Table 102. TRPharma Recent Development Table 103. Probiomed Company Information Table 104. Probiomed Business Overview Table 105. Probiomed Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Probiomed Rituximab Injection Product Portfolio Table 107. Probiomed Recent Development Table 108. Lexicare Pharma Company Information Table 109. Lexicare Pharma Business Overview Table 110. Lexicare Pharma Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Lexicare Pharma Rituximab Injection Product Portfolio Table 112. Lexicare Pharma Recent Development Table 113. Kavya Pharma Company Information Table 114. Kavya Pharma Business Overview Table 115. Kavya Pharma Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Kavya Pharma Rituximab Injection Product Portfolio Table 117. Kavya Pharma Recent Development Table 118. Intas Pharmaceuticals Company Information Table 119. Intas Pharmaceuticals Business Overview Table 120. Intas Pharmaceuticals Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Intas Pharmaceuticals Rituximab Injection Product Portfolio Table 122. Intas Pharmaceuticals Recent Development Table 123. Hetero Group Company Information Table 124. Hetero Group Business Overview Table 125. Hetero Group Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hetero Group Rituximab Injection Product Portfolio Table 127. Hetero Group Recent Development Table 128. Healthiza Lifescience Company Information Table 129. Healthiza Lifescience Business Overview Table 130. Healthiza Lifescience Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Healthiza Lifescience Rituximab Injection Product Portfolio Table 132. Healthiza Lifescience Recent Development Table 133. Dr Reddy’s Laboratories Company Information Table 134. Dr Reddy’s Laboratories Business Overview Table 135. Dr Reddy’s Laboratories Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Dr Reddy’s Laboratories Rituximab Injection Product Portfolio Table 137. Dr Reddy’s Laboratories Recent Development Table 138. Celltrion Company Information Table 139. Celltrion Business Overview Table 140. Celltrion Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Celltrion Rituximab Injection Product Portfolio Table 142. Celltrion Recent Development Table 143. Cadila Pharmaceuticals Company Information Table 144. Cadila Pharmaceuticals Business Overview Table 145. Cadila Pharmaceuticals Rituximab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Cadila Pharmaceuticals Rituximab Injection Product Portfolio Table 147. Cadila Pharmaceuticals Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Rituximab Injection Distributors List Table 151. Rituximab Injection Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Rituximab Injection Product Image Figure 2. Global Rituximab Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rituximab Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Rituximab Injection Sales (2021-2032) & (k units) Figure 5. Global Rituximab Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Rituximab Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100 ml Image Figure 9. 500 ml Image Figure 10. Global Rituximab Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Rituximab Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Rituximab Injection Sales Market Share by Type (2021-2032) Figure 13. Global Rituximab Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Rituximab Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Rituximab Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Others Image Figure 19. Global Rituximab Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Rituximab Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Rituximab Injection Sales Market Share by Application (2021-2032) Figure 22. Global Rituximab Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Rituximab Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Rituximab Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Rituximab Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Rituximab Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Rituximab Injection Sales Market Share by Country (2021-2032) Figure 39. China Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Rituximab Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Rituximab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Rituximab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Rituximab Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Rituximab Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Rituximab Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Rituximab Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Rituximab Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Rituximab Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Rituximab Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Rituximab Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Rituximab Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Rituximab Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Rituximab Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 100 ml
  • 500 ml
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Innovent Biologics
  • Roche
  • Pfizer
  • Fosun-Pharmaceutical
  • Shanghai Henlius Biotech
  • Amgen
  • Zenotech Laboratories
  • TRPharma
  • Probiomed
  • Lexicare Pharma
  • Kavya Pharma
  • Intas Pharmaceuticals
  • Hetero Group
  • Healthiza Lifescience
  • Dr Reddy’s Laboratories
  • Celltrion
  • Cadila Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rituximab Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rituximab Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Rituximab Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Rituximab Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Rituximab Injection Market Dynamics
  1. 2.1 Rituximab Injection Industry Trends
  2. 2.2 Rituximab Injection Industry Drivers
  3. 2.3 Rituximab Injection Industry Opportunities and Challenges
  4. 2.4 Rituximab Injection Industry Restraints
3 Rituximab Injection Market by Manufacturers
  1. 3.1 Global Rituximab Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Rituximab Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Rituximab Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Rituximab Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rituximab Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Rituximab Injection Manufacturers, Product Type & Application
  7. 3.7 Global Rituximab Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rituximab Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rituximab Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rituximab Injection Tier 1, Tier 2, and Tier 3
4 Rituximab Injection Market by Type
  1. 4.1 Rituximab Injection Type Introduction
  2. 4.1.1 100 ml
  3. 4.1.2 500 ml
  4. 4.2 Global Rituximab Injection Sales by Type
  5. 4.2.1 Global Rituximab Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rituximab Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Rituximab Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Rituximab Injection Revenue by Type
  9. 4.3.1 Global Rituximab Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rituximab Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Rituximab Injection Revenue Market Share by Type (2021-2032)
5 Rituximab Injection Market by Application
  1. 5.1 Rituximab Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Rituximab Injection Sales by Application
  6. 5.2.1 Global Rituximab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rituximab Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Rituximab Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Rituximab Injection Revenue by Application
  10. 5.3.1 Global Rituximab Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rituximab Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Rituximab Injection Revenue Market Share by Application (2021-2032)
6 Global Rituximab Injection Sales by Region
  1. 6.1 Global Rituximab Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rituximab Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Rituximab Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Rituximab Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rituximab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Rituximab Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Rituximab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Rituximab Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Rituximab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Rituximab Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Rituximab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Rituximab Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Rituximab Injection Revenue by Region
  1. 7.1 Global Rituximab Injection Revenue by Region
  2. 7.1.1 Global Rituximab Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Rituximab Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Rituximab Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Rituximab Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Rituximab Injection Revenue (2021-2032)
  8. 7.2.2 North America Rituximab Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Rituximab Injection Revenue (2021-2032)
  11. 7.3.2 Europe Rituximab Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Rituximab Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Rituximab Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Rituximab Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Rituximab Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Innovent Biologics
  2. 8.1.1 Innovent Biologics Company Information
  3. 8.1.2 Innovent Biologics Business Overview
  4. 8.1.3 Innovent Biologics Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Innovent Biologics Rituximab Injection Product Portfolio
  6. 8.1.5 Innovent Biologics Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Rituximab Injection Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Rituximab Injection Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Fosun-Pharmaceutical
  20. 8.4.1 Fosun-Pharmaceutical Company Information
  21. 8.4.2 Fosun-Pharmaceutical Business Overview
  22. 8.4.3 Fosun-Pharmaceutical Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fosun-Pharmaceutical Rituximab Injection Product Portfolio
  24. 8.4.5 Fosun-Pharmaceutical Recent Developments
  25. 8.5 Shanghai Henlius Biotech
  26. 8.5.1 Shanghai Henlius Biotech Company Information
  27. 8.5.2 Shanghai Henlius Biotech Business Overview
  28. 8.5.3 Shanghai Henlius Biotech Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Henlius Biotech Rituximab Injection Product Portfolio
  30. 8.5.5 Shanghai Henlius Biotech Recent Developments
  31. 8.6 Amgen
  32. 8.6.1 Amgen Company Information
  33. 8.6.2 Amgen Business Overview
  34. 8.6.3 Amgen Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Amgen Rituximab Injection Product Portfolio
  36. 8.6.5 Amgen Recent Developments
  37. 8.7 Zenotech Laboratories
  38. 8.7.1 Zenotech Laboratories Company Information
  39. 8.7.2 Zenotech Laboratories Business Overview
  40. 8.7.3 Zenotech Laboratories Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zenotech Laboratories Rituximab Injection Product Portfolio
  42. 8.7.5 Zenotech Laboratories Recent Developments
  43. 8.8 TRPharma
  44. 8.8.1 TRPharma Company Information
  45. 8.8.2 TRPharma Business Overview
  46. 8.8.3 TRPharma Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TRPharma Rituximab Injection Product Portfolio
  48. 8.8.5 TRPharma Recent Developments
  49. 8.9 Probiomed
  50. 8.9.1 Probiomed Company Information
  51. 8.9.2 Probiomed Business Overview
  52. 8.9.3 Probiomed Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Probiomed Rituximab Injection Product Portfolio
  54. 8.9.5 Probiomed Recent Developments
  55. 8.10 Lexicare Pharma
  56. 8.10.1 Lexicare Pharma Company Information
  57. 8.10.2 Lexicare Pharma Business Overview
  58. 8.10.3 Lexicare Pharma Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lexicare Pharma Rituximab Injection Product Portfolio
  60. 8.10.5 Lexicare Pharma Recent Developments
  61. 8.11 Kavya Pharma
  62. 8.11.1 Kavya Pharma Company Information
  63. 8.11.2 Kavya Pharma Business Overview
  64. 8.11.3 Kavya Pharma Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kavya Pharma Rituximab Injection Product Portfolio
  66. 8.11.5 Kavya Pharma Recent Developments
  67. 8.12 Intas Pharmaceuticals
  68. 8.12.1 Intas Pharmaceuticals Company Information
  69. 8.12.2 Intas Pharmaceuticals Business Overview
  70. 8.12.3 Intas Pharmaceuticals Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Intas Pharmaceuticals Rituximab Injection Product Portfolio
  72. 8.12.5 Intas Pharmaceuticals Recent Developments
  73. 8.13 Hetero Group
  74. 8.13.1 Hetero Group Company Information
  75. 8.13.2 Hetero Group Business Overview
  76. 8.13.3 Hetero Group Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hetero Group Rituximab Injection Product Portfolio
  78. 8.13.5 Hetero Group Recent Developments
  79. 8.14 Healthiza Lifescience
  80. 8.14.1 Healthiza Lifescience Company Information
  81. 8.14.2 Healthiza Lifescience Business Overview
  82. 8.14.3 Healthiza Lifescience Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Healthiza Lifescience Rituximab Injection Product Portfolio
  84. 8.14.5 Healthiza Lifescience Recent Developments
  85. 8.15 Dr Reddy’s Laboratories
  86. 8.15.1 Dr Reddy’s Laboratories Company Information
  87. 8.15.2 Dr Reddy’s Laboratories Business Overview
  88. 8.15.3 Dr Reddy’s Laboratories Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dr Reddy’s Laboratories Rituximab Injection Product Portfolio
  90. 8.15.5 Dr Reddy’s Laboratories Recent Developments
  91. 8.16 Celltrion
  92. 8.16.1 Celltrion Company Information
  93. 8.16.2 Celltrion Business Overview
  94. 8.16.3 Celltrion Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Celltrion Rituximab Injection Product Portfolio
  96. 8.16.5 Celltrion Recent Developments
  97. 8.17 Cadila Pharmaceuticals
  98. 8.17.1 Cadila Pharmaceuticals Company Information
  99. 8.17.2 Cadila Pharmaceuticals Business Overview
  100. 8.17.3 Cadila Pharmaceuticals Rituximab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cadila Pharmaceuticals Rituximab Injection Product Portfolio
  102. 8.17.5 Cadila Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rituximab Injection Value Chain Analysis
  2. 9.1.1 Rituximab Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rituximab Injection Production Mode & Process
  6. 9.2 Rituximab Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rituximab Injection Distributors
  9. 9.2.3 Rituximab Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst